BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16377478)

  • 1. CT screening for lung cancer: significance of diagnoses in its baseline cycle.
    Henschke CI; Shaham D; Yankelevitz DF; Kramer A; Kostis WJ; Reeves AP; Vazquez M; Koizumi J; Miettinen OS
    Clin Imaging; 2006; 30(1):11-5. PubMed ID: 16377478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules.
    Henschke CI; Yankelevitz DF; Mirtcheva R; McGuinness G; McCauley D; Miettinen OS;
    AJR Am J Roentgenol; 2002 May; 178(5):1053-7. PubMed ID: 11959700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds.
    Henschke CI; Yip R; Smith JP; Wolf AS; Flores RM; Liang M; Salvatore MM; Liu Y; Xu DM; Yankelevitz DF;
    AJR Am J Roentgenol; 2016 Dec; 207(6):1176-1184. PubMed ID: 27726410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
    AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds.
    Yankelevitz DF; Yip R; Smith JP; Liang M; Liu Y; Xu DM; Salvatore MM; Wolf AS; Flores RM; Henschke CI;
    Radiology; 2015 Nov; 277(2):555-64. PubMed ID: 26101879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT screening for lung cancer: update 2005.
    Henschke CI;
    Surg Oncol Clin N Am; 2005 Oct; 14(4):761-76. PubMed ID: 16226690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project.
    New York Early Lung Cancer Action Project Investigators
    Radiology; 2007 Apr; 243(1):239-49. PubMed ID: 17392256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size.
    Henschke CI; Yankelevitz DF; Miettinen OS;
    Arch Intern Med; 2006 Feb; 166(3):321-5. PubMed ID: 16476872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update of CT screening for lung cancer.
    International Early Lung Cancer Program Investigators
    Semin Ultrasound CT MR; 2005 Oct; 26(5):348-56. PubMed ID: 16274003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans.
    Henschke CI; Yankelevitz DF; Naidich DP; McCauley DI; McGuinness G; Libby DM; Smith JP; Pasmantier MW; Miettinen OS
    Radiology; 2004 Apr; 231(1):164-8. PubMed ID: 14990809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Cancer Deaths in the National Lung Screening Trial Attributed to Nonsolid Nodules.
    Yip R; Yankelevitz DF; Hu M; Li K; Xu DM; Jirapatnakul A; Henschke CI
    Radiology; 2016 Nov; 281(2):589-596. PubMed ID: 27378239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT screening for lung cancer: past and ongoing studies.
    Henschke CI; Shaham D; Yankelevitz DF; Altorki NK
    Semin Thorac Cardiovasc Surg; 2005; 17(2):99-106. PubMed ID: 16087075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of ACR Lung-RADS in a clinical CT lung screening program.
    McKee BJ; Regis SM; McKee AB; Flacke S; Wald C
    J Am Coll Radiol; 2015 Mar; 12(3):273-6. PubMed ID: 25176499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.
    Horeweg N; van der Aalst CM; Vliegenthart R; Zhao Y; Xie X; Scholten ET; Mali W; Thunnissen E; Weenink C; Groen HJ; Lammers JW; Nackaerts K; van Rosmalen J; Oudkerk M; de Koning HJ
    Eur Respir J; 2013 Dec; 42(6):1659-67. PubMed ID: 23845716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study.
    Henschke CI; Yip R; Yankelevitz DF; Smith JP;
    Ann Intern Med; 2013 Feb; 158(4):246-52. PubMed ID: 23420233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of automated lung nodule detection on low-dose computed tomography scans from a lung cancer screening program(1).
    Armato SG; Roy AS; Macmahon H; Li F; Doi K; Sone S; Altman MB
    Acad Radiol; 2005 Mar; 12(3):337-46. PubMed ID: 15766694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL; Fischman AJ
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.
    Lindell RM; Hartman TE; Swensen SJ; Jett JR; Midthun DE; Tazelaar HD; Mandrekar JN
    Radiology; 2007 Feb; 242(2):555-62. PubMed ID: 17255425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial.
    Maisonneuve P; Bagnardi V; Bellomi M; Spaggiari L; Pelosi G; Rampinelli C; Bertolotti R; Rotmensz N; Field JK; Decensi A; Veronesi G
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1778-89. PubMed ID: 21813406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overdiagnosis in chest radiographic screening for lung carcinoma: frequency.
    Yankelevitz DF; Kostis WJ; Henschke CI; Heelan RT; Libby DM; Pasmantier MW; Smith JP
    Cancer; 2003 Mar; 97(5):1271-5. PubMed ID: 12599235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.